Yingxi Xu
Tianjin University of Technology(CN)Sun Yat-sen University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Ludwig Cancer Research(CH)National Clinical Research(US)Institute of Hematology & Blood Diseases Hospital(CN)Xinxiang Medical University(CN)China Medical University(CN)University of Lausanne(CH)
Publications by Year
Research Areas
CAR-T cell therapy research, Immune Cell Function and Interaction, Acute Myeloid Leukemia Research, Virus-based gene therapy research, Immune cells in cancer
Most-Cited Works
- → Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence(2014)274 cited
- → 2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies(2019)185 cited
- → SOX2 promotes tumor metastasis by stimulating epithelial-to-mesenchymal transition via regulation of WNT/β-catenin signal network(2013)183 cited
- → SOX2 Gene Regulates the Transcriptional Network of Oncogenes and Affects Tumorigenesis of Human Lung Cancer Cells(2012)163 cited
- → Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia(2020)108 cited
- → Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells(2018)